BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2025 8:12:17 AM | Browse: 114 | Download: 709
 |
Received |
|
2024-07-27 08:02 |
|
Peer-Review Started |
|
2024-07-27 08:02 |
|
First Decision by Editorial Office Director |
|
2024-10-11 09:55 |
|
Return for Revision |
|
2024-10-11 09:55 |
|
Revised |
|
2024-10-25 05:45 |
|
Publication Fee Transferred |
|
2024-11-28 10:47 |
|
Second Decision by Editor |
|
2024-11-21 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-22 12:50 |
|
Articles in Press |
|
2024-11-22 12:50 |
|
Edit the Manuscript by Language Editor |
|
2024-12-07 23:42 |
|
Typeset the Manuscript |
|
2024-12-17 09:07 |
|
Publish the Manuscript Online |
|
2025-01-18 08:12 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Malignant perivascular epithelioid cell tumor of the colorectum: Clinicopathological characterization of seven cases, with diagnosis and treatment process
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ming-Fei Ma, Zhen-Yu Chi, Li-Juan Zhao, Wei Zhai, Wen Zhong and Song Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Song Wang, MD, PhD, Surgeon, Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. 592031959@qq.com |
| Key Words |
Perivascular epithelioid cell tumor; Colorectum; Malignant; Resection; Mammalian target of rapamycin inhibitor |
| Core Tip |
Perivascular epithelioid cell tumor (PEComa) of the colorectum is exceedingly rare, and inexperience in therapy and poor prognosis are obstacles currently encountered. This report retrieved seven cases censored at 3-month intervals with clinicopathological, therapeutic and follow-up (median, 44 months) details. We found patients benefited from R0 resection, which was superior to systemic therapy. The high risk for recurrence was within two years postoperatively. The median progression-free survival exceeded 38 months, longer than previously reported. Therefore, radical or extended resection is the key to prolonging survival of colorectal malignant PEComa. |
| Publish Date |
2025-01-18 08:12 |
| Citation |
Ma MF, Chi ZY, Zhao LJ, Zhai W, Zhong W, Wang S. Malignant perivascular epithelioid cell tumor of the colorectum: Clinicopathological characterization of seven cases, with diagnosis and treatment process. World J Gastrointest Oncol 2025; 17(2): 99662 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i2/99662.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i2.99662 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
